ArticleJournal of translational medicine2021
From biobank and data silos into a data commons: convergence to support translational medicine.
Article in Journal of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 28 citations in OpenAlex.
- Characterizing core outcomes of responsible stewardship for human genomic data in the cloud.BMC medical genomics · 2026Article
- dsLassoCov: a federated Lasso approach incorporating covariate control.Scientific reports · 2026Article
- Knowledge Mapping of Human Genetic Variation in Multiomics Biomarker Translation: A Bibliometric Analysis.Human mutation · 2026Article
- Current Bioinformatics Tools in Precision Oncology.MedComm · 2025Review
- Simple controls exceed best deep learning algorithms and reveal foundation model effectiveness for predicting genetic perturbations.Bioinformatics (Oxford, England) · 2025Article
- Status and Opportunities of Machine Learning Applications in Obstructive Sleep Apnea: A Narrative Review.medRxiv : the preprint server for health sciences · 2025Article
- How life-cycle real-world evidence can bridge evidentiary gaps in precision oncology.Frontiers in medicine · 2025Article
- Status and opportunities of machine learning applications in obstructive sleep apnea: A narrative review.Computational and structural biotechnology journal · 2025Review
- Review
- Review
- Building Flexible, Scalable, and Machine Learning-Ready Multimodal Oncology Datasets.Sensors (Basel, Switzerland) · 2024Article
- Data Liberation and Crowdsourcing in Medical Research: The Intersection of Collective and Artificial Intelligence.Radiology. Artificial intelligence · 2024Article
- An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease.Nature medicine · 2023Article
- Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking.Journal of personalized medicine · 2023Review
- Banking on a new understanding: translational opportunities from veterinary biobanks.GeroScience · 2023Review
- Democratizing clinical-genomic data: How federated platforms can promote benefits sharing in genomics.Frontiers in genetics · 2022Article
- Biobanking in the digital pathology era.Oncology research · 2021Article
- A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease.Annals of hepatologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo drive translational medicine, modern day biobanks need to integrate with other sources of data (clinical, genomics) to support novel data-intensive research. Currently, vast amounts of research and clinical data remain in silos, held and managed by individual researchers, operating under different standards and governance structures; a framework that impedes sharing and effective use of data. In this article, we describe the journey of British Columbia's Gynecological Cancer Research Program (OVCARE) in moving a traditional tumour biobank, outcomes unit, and a collection of data silos, into an integrated data commons to support data standardization and resource sharing under collaborative governance, as a means of providing the gynecologic cancer research community in British Columbia access to tissue samples and associated clinical and molecular data from thousands of patients.
resultsThrough several engagements with stakeholders from various research institutions within our research community, we identified priorities and assessed infrastructure needs required to optimize and support data collections, storage and sharing, under three main research domains: (1) biospecimen collections, (2) molecular and genomics data, and (3) clinical data. We further built a governance model and a resource portal to implement protocols and standard operating procedures for seamless collections, management and governance of interoperable data, making genomic, and clinical data available to the broader research community.
conclusionsProper infrastructures for data collection, sharing and governance is a translational research imperative. We have consolidated our data holdings into a data commons, along with standardized operating procedures to meet research and ethics requirements of the gynecologic cancer community in British Columbia. The developed infrastructure brings together, diverse data, computing frameworks, as well as tools and applications for managing, analyzing, and sharing data. Our data commons bridges data access gaps and barriers to precision medicine and approaches for diagnostics, treatment and prevention of gynecological cancers, by providing access to large datasets required for data-intensive science.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.